Understanding The Structure and Functions of IRF2BPL: A Potential Drug Target Or Biomarker

Target Name: IRF2BPL

NCBI ID: G64207

IRF2BPL

Understanding The Structure and Functions of IRF2BPL: A Potential Drug Target Or Biomarker

Introduction IRF2BPL (Immunoreceptor Fusion Protein 2B subunit) is a protein that is expressed in various tissues of the body, including the immune system, and plays a crucial role in the regulation of immune responses. IRF2BPL is a key component of the immunoreceptor fusion complex ( IRFC), which is a protein complex that is involved in the regulation of T cell responses. In recent years, researchers have become increasingly interested in IRF2BPL as a potential drug target or biomarker, due to its unique structure and its involvement in various biological processes.

Structure and Functions

Structure of IRF2BPL

IRF2BPL is a 21 kDa protein that consists of two heavy chains and two light chains. The heavy chains contain four variable regions, while the light chains contain one variable region and one constant region. The variable regions contain the majority of the protein's surface features, including four immunoglobulin (Ig) domains.

One of the unique features of IRF2BPL is its ability to form a monomeric species, which means that it can exist as a single protein molecule in the cell. This monomeric state allows IRF2BPL to display a variety of different conformational changes, which can influence its functions.

Functions of IRF2BPL

IRF2BPL is involved in the regulation of T cell responses, as well as other immune responses. It plays a key role in the development and maintenance of CD4+ T cells, which are a crucial part of the immune system. IRF2BPL helps to regulate the activation and proliferation of these cells, as well as their survival and differentiation.

IRF2BPL is also involved in the regulation of inflammation. It helps to control the production of pro-inflammatory cytokines, which can contribute to the development of inflammatory diseases. Additionally, IRF2BPL is involved in the regulation of cell adhesion and migration, which are important processes that are involved in the development of tissues and organs.

Drug Targeting

IRF2BPL is a potential drug target due to its unique structure and its involvement in various biological processes. Because it is a monomeric protein, it is possible to target specific regions of the protein that are involved in its functions. This can be done through various methods , including genetic modification, site-directed mutagenesis, and cell-based assays.

One approach to targeting IRF2BPL is to use small molecules to modify its structure and influence its functions. This can be done through a variety of different methods, including chemical screening, high-throughput screening, and cell-based assays. By using these methods, researchers have been able to identify small molecules that are able to interact with IRF2BPL and influence its functions.

Another approach to targeting IRF2BPL is to use antibodies to selectively bind to it. This can be done through various methods, including affinity purification, cell-based assays, and mass spectrometry. By using antibodies, researchers have been able to study the interactions between IRF2BPL and other proteins, and have identified potential targets for drug development.

Biomarkers

IRF2BPL is also a potential biomarker for various diseases. Its involvement in the regulation of T cell responses makes it an attractive target for cancer therapies. By using antibodies or small molecules to modify IRF2BPL, researchers have been able to study its functions and identify potential targets for cancer therapies.

IRF2BPL is also a potential biomarker for autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. These diseases are characterized by the immune system attacking the body's own tissues, and the use of IRF2BPL as a biomarker could help to identify potential therapeutic targets.

Conclusion

In conclusion, IRF2BPL is a protein that is involved in various biological processes and could be a potential drug target or biomarker. Its unique structure and its involvement in the regulation of T cell responses and other immune responses make it an attractive target for small molecules and antibodies. Further research is needed to fully understand the functions of IRF2BPL and its potential as a drug target

Protein Name: Interferon Regulatory Factor 2 Binding Protein Like

Functions: Probable E3 ubiquitin protein ligase involved in the proteasome-mediated ubiquitin-dependent degradation of target proteins (PubMed:29374064). Through the degradation of CTNNB1, functions downstream of FOXF2 to negatively regulate the Wnt signaling pathway (PubMed:29374064). Probably plays a role in the development of the central nervous system and in neuronal maintenance (Probable). Also acts as a transcriptional regulator of genes controlling female reproductive function. May play a role in gene transcription by transactivating GNRH1 promoter and repressing PENK promoter (By similarity)

The "IRF2BPL Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IRF2BPL comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets